Hepatitis: all 3,372 studies
Page 28 of 34. Open to participants first (195), then studies with results posted, then the rest; newest registration first within each.
- A Study of RO5024048 in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 1 or 4CompletedNCT01057667Phase 2
- PegIFN Alfa-2a and RBV for 16 or 24 Weeks in Patients With Chronic Hepatitis C(CHC) 2 With Rapid Virologic Response(RVR)Status unknownNCT01056172Phase 4
- Efficacy of the Therapeutic Vaccine TG4040 Combined With Pegylated Interferon and Ribavirin in Chronic HCV PatientsCompletedNCT01055821Phase 2
- Safety and Efficacy Study in Hepatitis C Patients With PHN121TerminatedNCT01052090Phase 1/2
- An Anti-viral Combination Study With Japanese Hepatitis C Infection (HCV) SubjectCompletedNCT01051414Phase 2
- Notification of Donors With Positive Microbiology MarkersCompletedNCT01050881
- Prevention of Hepatitis B Virus Reinfection After Liver Transplantation With EntecavirCompletedNCT01046799Phase 3
- TMC435-TiDP16-C113: A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics of TMC435CompletedNCT01046058Phase 1
- Hepatitis C in a Cohort of Patients With Maintenance Therapy for Opiate Dependence - Prevalence, Severity and Outcome of Antiviral TherapyCompletedNCT01045278Phase 4
- Study in Japan of the Safety And Antiviral Activity in Adults With Chronic Hepatitis B Current Lamivudine TherapyCompletedNCT01037166Phase 2
- An Open-Label Rollover Study of Entecavir (BMS-200475) in Adults With Chronic Hepatitis B InfectionCompletedNCT01037062Phase 2
- Epidemiological Study to Evaluate the Management of Patients With Chronic Hepatitis C and Previous Treatment FailureCompletedNCT01033045
- Study of BMS-650032 With Peginterferon Alfa-2a Plus RibavirinCompletedNCT01030432Phase 2
- Dose Escalation of Interleukin-1 (IL-7) Added on Antiviral Treatment and Vaccination in HBeAg-negative Chronic Hepatitis B Virus (HBV) Infected PatientsStatus unknownNCT01027065Phase 1/2
- Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis BCompletedNCT01026610Phase 2
- The Effects of Oral Hypoglycemic Agents on Chronic Hepatitis C Patients Receiving Peg-Intron Plus RibavirinStatus unknownNCT01025765Phase 4
- Dose Escalation Study of IL-7 and Bi-therapy in HCV Patients Resistant After 12 Weeks of Bi-therapy (ECLIPSE 1)CompletedNCT01025596Phase 1/2
- Cell Bound Complement Activation Proteins as Markers of Liver InjuryWithdrawnNCT01025531
- Dose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in HCV Genotype 1 or 4 Patients Resistant to Bitherapy AloneStatus unknownNCT01025297Phase 1/2
- Dose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in Asiatic HCV Patients Resistant to BitherapyStatus unknownNCT01024894Phase 1/2
- A Study to Assess DV-601 in Subjects With Chronic Hepatitis BCompletedNCT01023230Phase 1
- A Phase II Dose Response Study in Japan in Chronic Hepatitis BCompletedNCT01022801Phase 2
- TMC435-TiDP16-C121: A Study Comparing 2 Tablet Formulations of TMC435 to an Established Capsule Formulation and Evaluating the Effect of Food on Blood Levels of TMC435CompletedNCT01022125Phase 1
- A Study in Japan of the Safety and Antiviral Activity With Chronic Hepatitis B InfectionCompletedNCT01020565Phase 2
- Arabinoxylan Rice Bran (MGN-3/Biobran) for the Treatment of Hepatocellular Carcinoma and Hepatitis B and C InfectionCompletedNCT01018381Not applicable
- Clinical Trial of Recombinant Hepatitis E VaccineCompletedNCT01014845Phase 3
- Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of CareCompletedNCT01012895Phase 2
- Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin (MK-2355-004)CompletedNCT01011166Phase 2
- Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4CompletedNCT01006031Phase 2/3
- Telbivudine Versus Lamivudine for Maintenance Therapy of Patients With Chronic Hepatitis B and Negative HBV Viral Load After 6 Month of Treatment With TelbivudineTerminatedNCT01005238Phase 4
- Efficacy and Safety Study of PEG-rIL-29 Plus Ribavirin to Treat Chronic Hepatitis C Virus InfectionStatus unknownNCT01001754Phase 2
- ADHEPTA Study: Adherence Questionnaire in Hepatitis CCompletedNCT00998621
- Simvastatin for the Treatment of Chronic Hepatitis BCompletedNCT00994773Phase 1
- Ribavirin Pre-treatment Followed by Combined Standard Therapy in Hepatitis C Virus (HCV) RecipientsCompletedNCT00993122Phase 4
- Inflammation, Immune Activation and Portal Hypertension in Alcoholic HepatitisCompletedNCT00992888Not applicable
- Entecavir Plus Adefovir in Lamivudine-Resistant PatientsWithdrawnNCT00986778Phase 4
- Genotype Based Personalized Prescription of NevirapineCompletedNCT00986063Phase 4
- Blood Antioxidant Status in Chronic Hepatitis C Patients Before and After Antioxidant Supplementation: a Randomized Clinical TrialCompletedNCT00983164Not applicable
- Adaptive-design Dose Finding Study to Assess the Antiviral Efficacy and Safety of NIM811 Administered in Combination With Standard of Care (SOC) in Relapsed Hepatitis C Virus 1 (HCV-1) Infected PatientsCompletedNCT00983060Phase 2
- Micro RNA-122 and the Clinical Course of Patients With Chronic Hepatitis CStatus unknownNCT00980161
- Clinical Performance of Abbott RealTime Hepatitis C Virus (HCV) Genotype II TestCompletedNCT00979979
- SPC3649 Multiple Dose Study in Healthy VolunteersCompletedNCT00979927Phase 1
- Double Filtration Plasmapheresis for Hepatitis C Virus (HCV) Genotype 1 Patients With High Viral LoadTerminatedNCT00977054Phase 4
- Identifying the Gaps in the Diagnosis and Management of Hepatitis CWithdrawnNCT00976781
- Continue Entecavir Rollover From ChinaCompletedNCT00975091Phase 3
- Efficacy and Safety of the Extracorporeal Liver Assist Device (ELAD) in Acute on Chronic HepatitisCompletedNCT00973817Phase 2/3
- VX-950-TiDP24-C136 - A Trial to Evaluate the Effect of Telaprevir (TVR) on the Results of Electrocardiograms (Electric Recording of the Heart) in Healthy VolunteersCompletedNCT00973388Phase 1
- Hepatitis B Surface Antigen(HBsAg) Loss in Chronic Hepatitis B Patients With Low Viral LoadCompletedNCT00973219Not applicable
- Multiple Dose Study In Treatment Naive Subjects Infected With Hepatitis C VirusCompletedNCT00971308Phase 1
- Proof-of-concept Study to Evaluate the Safety and Immunomodulatory Effects of SCV 07 as Monotherapy or in Combination With Ribavirin in Noncirrhotic Subjects With Chronic Hepatitis C Who Have RelapsedCompletedNCT00968357Phase 2
- Pharmacokinetic/Pharmacodynamic of Albinterferon Alfa-2b in Chronic Hepatitis B, eAg+, Infection SubjectsTerminatedNCT00964665Phase 1/2
- A Study of RO5190591 (Danoprevir) in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1 Virus InfectionCompletedNCT00963885Phase 2
- A Study of Pegasys Monotherapy in Patients With Chronic Hepatitis B Who Have Participated in Previous StudiesCompletedNCT00962975Phase 1
- Safety and Tolerability Study of the Monoclonal Antibody CT-011 in Patients With Chronic Hepatitis C Genotype I InfectionTerminatedNCT00962936Phase 1/2
- N-Acetylcysteine in Severe Acute Alcoholic HepatitisCompletedNCT00962442Phase 3
- TACE and Adefovir Compared With Transarterial Chemoembolization (TACE) Alone for Hepatitis B Virus (HBV)-Related Unresectable Hepatocellular Carcinoma (HCC)Status unknownNCT00960518Phase 2
- Alcohol Use Reduction in Methadone Individuals With Hepatitis C Virus(HCV)CompletedNCT00958763Phase 2
- Prospective Anti-Hepatitis C Virus (Anti-HCV) Trial of Peg-Interferon and Ribavirin in Subjects of First Nations, Metis and Caucasian EthnicityCompletedNCT00957866Phase 4
- PEG-IFN Plus Ribavirin Combination Therapy for Older PatientsStatus unknownNCT00956982Not applicable
- 480 STUDY: Phase 2b Study of Locteron Plus Ribavirin to Treat Hepatitis C Virus (HCV)CompletedNCT00953589Phase 2
- Study in Healthy Volunteers to Evaluate a Human Monoclonal Antibody Against Hepatitis CCompletedNCT00952263Phase 1
- Observational Prospective Registry of the Efficacy, Safety, and Adherence to Infergen® in Patients Infected With Hep CWithdrawnNCT00951223
- Influence of Antiviral Therapy on Bone Mineral Density and Metabolism in Patients With Chronic Hepatitis CCompletedNCT00948220Phase 4
- Investigation of Hepatitis B and Hepatitis C in TaiwanCompletedNCT00946010
- Safety and Tolerability Study of Clemizole Hydrochloride to Treat Hepatitis C in Subjects Who Are Treatment-NaiveCompletedNCT00945880Phase 1
- High Dose Ribavirin in the Treatment of Chronic Hepatitis CCompletedNCT00944684Phase 2
- A Study of Combination Treatment With Pegasys (Peginterferon Alfa) and Copegus (Ribavirin)in Patients With Chronic Hepatitis CCompletedNCT00940420Phase 4
- Efficacy and Safety Study of Telbivudine to Prevent Perinatal TransmissionStatus unknownNCT00939068Phase 4
- HIDIT II - PegIFN-alfa2a Plus Tenofovir in Chronic Delta HepatitisCompletedNCT00932971Phase 2
- Seroimmunity 2007 and Sub Study of the Swedish Population Regarding Vaccine Preventable DiseaseStatus unknownNCT00932269
- Incidence of Hepatitis B Reactivation in Non-Hodgkin's Lymphoma PatientsStatus unknownNCT00931229Not applicable
- Angiotensin Receptor Blockade as an Anti-Fibrotic Intervention in Patients With Chronic Hepatitis CWithdrawnNCT00930995Phase 2
- Pioglitazone vs. Placebo in Association With Pegylated Interferon and Ribavirin in HCV Patients With Insulin ResistanceTerminatedNCT00927290Phase 3
- Prophylactic Use of Entecavir for Non-Hodgkin's Lymphoma Patients With Resolved Hepatitis BCompletedNCT00926757Phase 4
- Efficacy of Actos Lipitor Pegasys & Ribavirin in CHC GT 1 Patients Who Relapsed or Nonresponded to Peg/RibaCompletedNCT00926614Phase 4
- Serological Evaluation of Varicella and Hepatitis A Vaccines Using Injector DeliveryStatus unknownNCT00926419Phase 2/3
- Hepatitis B Virus (HBV) Prevention for Homeless at Risk for HBV/Hepatitis C Virus (HCV)/HIVCompletedNCT00926146Not applicable
- The Effects of Mogroside Sweetener on Viral Load in TreatmenT Naive Genotype 1 (GT 1) Subjects CHCCompletedNCT00926120Phase 2
- Pioglitazone on Viral Kinetics, Cytokines and Innate Immunity in Insulin Resistant CHC GT 1 SubjectsCompletedNCT00926016Not applicable
- Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Positive Chronic Hepatitis BStatus unknownNCT00921180Phase 4
- Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Negative Chronic Hepatitis BStatus unknownNCT00917761Phase 4
- Pegylated Interferon Alfa-2a for Dialysis Patients With Acute Hepatitis CCompletedNCT00917358Phase 4
- A Study to Investigate the Potential Pharmacokinetic Interaction Between TMC435 and MethadoneCompletedNCT00915564Phase 1
- Effect of Chronic Viral Hepatitis on the Pharmacokinetics of NRL972.CompletedNCT00915057Phase 2
- A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore AreaCompletedNCT00913757
- Pharmacokinetics of Multiple Ascending Doses of VCH-222 in Subjects With Chronic Hepatitis C InfectionCompletedNCT00911963Phase 1/2
- Individualized Duration of Peg-interferon/Ribavirin Treatment of Hepatitis CCompletedNCT00910975Phase 4
- Interactions of Hepatitis C Viral (HCV) Dynamics and Immune Activation in HIV Coinfected Patients During HCV TreatmentCompletedNCT00909129Not applicable
- Pharmacokinetics and Safety of Single-Dose Telbivudine in Children and Adolescents With Chronic Hepatitis BCompletedNCT00907894Phase 1
- ANRS HC20 Effectiveness of an Optimized Anti HCV PegIFN-alpha2a + Ribavirin on Sustained Virological Response in Patients With HCV Genotype 1 and 4 Non Responders and Co-infected With HIVCompletedNCT00901524Phase 2
- Study to Evaluate Different Regimens of Vaniprevir (MK7009) for the Treatment of Chronic Genotype 1 Hepatitis C Virus Infection in Treatment-naive Patients (MK-7009-019)(WITHDRAWN)WithdrawnNCT00895882Phase 2
- Efficacy and Safety of Intramuscular HBIG Grifols for the Prevention of Recurrence After Liver TransplantationCompletedNCT00895713Phase 2
- Safety and Efficacy Study of LB80380 in the Patients With Lamivudine-Refractory Chronic Hepatitis BCompletedNCT00895596Phase 1/2
- Trends in Risk Factors for Mother-to-Child Transmission of Hepatitis C Among a Southern European PopulationCompletedNCT00894257
- Community-based Hepatitis B Interventions for Hmong AdultsCompletedNCT00888407Not applicable
- PEG-IFN in HBV Patients With Incomplete Response to NACompletedNCT00883844Phase 4
- Pilot Study of Betaine + Combination Antiviral Therapy for Chronic Hepatitis C Genotype 1 Non-responder/RelapsersTerminatedNCT00882193Early Phase 1
- Peginterferon Alfa-2a Plus Ribavirin Combination Treatment in Chronic Hepatitis C Post-Renal Transplant PatientsCompletedNCT00881582Phase 4
- Activation of Hepatitis B Virus (HBV) in Hepatitis B Surface Antigen (HBsAg) - Negative But Hepatitis B Core Antibody (Anti-HBc) - Positive PatientsCompletedNCT00881036
- Immunogenicity and Safety of Primary and Booster Vaccination With DTPa-HBV-IPV/Hib VaccineCompletedNCT00880477Phase 3